
0:15
In this brief segment, the speaker explains that currently no insurance plans cover stem cell exosome therapy. They note ongoing efforts to achieve insurance coverage in the future. To mitigate the lack of coverage, the provider offers both internal financing and third‑party financing options, aiming to make the therapy accessible to a broader audience.










